Atea Pharmaceuticals Inc Cash Flow Quality Index
Atea Pharmaceuticals Inc cash flow quality index. Atea Pharmaceuticals Inc (AVIR) has a Cash Flow Quality Index of -0.64x as of December 2021. Operating cash flow of $-75.42 Million is below net income of $117.13 Million, suggesting accrual-heavy earnings not yet converted to cash. See Atea Pharmaceuticals Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Atea Pharmaceuticals Inc (2021–2021)
Cash flow quality index of Atea Pharmaceuticals Inc from 2021 to 2021. Historical Cash Flow Quality Index for Atea Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore AVIR operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Atea Pharmaceuticals Inc Cash Flow Quality Index by Year (2021–2021)
Atea Pharmaceuticals Inc cash flow quality index by year from 2021 to 2021. Year-by-year earnings quality comparison for Atea Pharmaceuticals Inc. For the full cash flow conversion analysis, see Atea Pharmaceuticals Inc cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.72x | $-87.00 Million | $121.19 Million | — |